S-Ruxolitinib 鲁索利替尼

¥498-3140
TargetMol
USA
2022-08-07 00:44

南京莱富赛生物科技有限公司

我要认领
南京莱富赛生物科技有限公司
市场部
025-58868422
info@lifescimall.com
3039583090
产品属性
产品说明

ID:T3066

ID:T3066

PURITY:0.9975

PURITY:0.9975

Formula:C17H18N6

Formula:C17H18N6

MolWt:360.36

MolWt:360.36

Appearance:白色粉末

Appearance:白色粉末

Solubility:G4DMSO 61 mg/mL;Water <1 mg/mL

Solubility:G4DMSO 61 mg/mL;Water <1 mg/mL

Bioactivity:Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.

Bioactivity:Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.

Status:FDA

Status:FDA

Pathways:JAK/STAT Signaling

Pathways:JAK/STAT Signaling

Target:JAK inhibitor

Target:JAK inhibitor

Receptor:JAK1, JAK2

Receptor:JAK1, JAK2